What is a key aspect of posttransplant management to prevent rejection?

What is a key aspect of posttransplant management to prevent rejection?

• A. Anticoagulants
• B. Immunosuppressants
• C. Beta blockers
• D. Diuretics

Answer: (B)

Preventing organ rejection after transplantation relies on immunosuppressants that blunt the immune system’s response to the new organ. These medications suppress T-cell activation and proliferation, helping the graft survive long term. They are usually given in a combination to achieve enough suppression to prevent rejection while balancing the risk of infections and drug toxicities. Monitoring is essential: drug levels, kidney function, blood pressure, glucose, and vigilance for infection ensure the regimen remains effective and safe. Other drug classes, like anticoagulants, beta blockers, or diuretics, address different posttransplant needs and do not primarily prevent rejection.

Preventing organ rejection after transplantation relies on immunosuppressants that blunt the immune system’s response to the new organ. These medications suppress T-cell activation and proliferation, helping the graft survive long term. They are usually given in a combination to achieve enough suppression to prevent rejection while balancing the risk of infections and drug toxicities. Monitoring is essential: drug levels, kidney function, blood pressure, glucose, and vigilance for infection ensure the regimen remains effective and safe. Other drug classes, like anticoagulants, beta blockers, or diuretics, address different posttransplant needs and do not primarily prevent rejection.